Andere Kunden interessierten sich auch für
![The Operative Atlas of Neurosurgery, Vol. I]( "The Operative Atlas of Neurosurgery, Vol. I")
The Operative Atlas of Neurosurgery, Vol. I63,99 €![Al-Mefty's Meningiomas]( "Al-Mefty's Meningiomas")
Al-Mefty's Meningiomas284,99 €![Oncology of CNS Tumors]( "Oncology of CNS Tumors")
Oncology of CNS Tumors148,99 €![The Fractal Geometry of the Brain]( "The Fractal Geometry of the Brain")
The Fractal Geometry of the Brain168,99 €![Fluorescence-Guided Surgery]( "Fluorescence-Guided Surgery")
Fluorescence-Guided Surgery113,99 €![Surgical Oncology: Fluorescence-Guided Surgery]( "Surgical Oncology: Fluorescence-Guided Surgery")
Surgical Oncology: Fluorescence-Guided Surgery148,99 €![The Fractal Geometry of the Brain]( "The Fractal Geometry of the Brain")
The Fractal Geometry of the Brain219,99 €
The definitive textbook on state-of-the-art fluorescence-guided neurosurgery
Advances in fluorescence-guided surgery (FGS) have resulted in a paradigm shift in neurosurgical approaches to neuro-oncological and cerebrovascular pathologies. Edited by two of the foremost authorities on the topic, Fluorescence-Guided Neurosurgery: Neuro-oncology and Cerebrovascular Applications encompasses the depth and breadth of this groundbreaking, still nascent technology. The book reflects significant contributions made by world renowned neurosurgeons Constantinos Hadjipanayis, Walter Stummer, and esteemed contributors on the growing uses of 5-aminolevulinic acid (5-ALA) and other FGS agents.
The European Medicine Agency approved 5-ALA in 2007, heralding the birth of FGS globally. In 2017, the U.S. Food and Drug Administration approved 5-ALA (Gleolan) as an imaging agent to facilitate realtime detection and visualization of malignant tissue during glioma surgery. In the two decades since Dr. Stummer's initial description of 5-ALA FGS in a human patient, major strides have been made in its practical applications, leading to improved resection outcomes. As FGS is increasingly incorporated into neurosurgical practice, it holds promise for future innovations. Generously-illustrated and enhanced with online videos, this textbook is the definitive resource on the subject.
Key Features
- The improved efficacy of 5-ALA for resecting high- and low-grade gliomas, recurrences, meningiomas, brain metastases, spinal cord tumors, pediatric brain tumors, and other adult tumors
- The future of fluorescence, including potentially powerful new fluorophores molecularly targeted specifically to tumors
- The use of the fluorescent agent indocyanine green (ICG) for brain tumors, cerebral aneurysms, AVMs, and cerebral vascularization
- Special topics such as fluorescein, illuminating tumor paint, confocal
Advances in fluorescence-guided surgery (FGS) have resulted in a paradigm shift in neurosurgical approaches to neuro-oncological and cerebrovascular pathologies. Edited by two of the foremost authorities on the topic, Fluorescence-Guided Neurosurgery: Neuro-oncology and Cerebrovascular Applications encompasses the depth and breadth of this groundbreaking, still nascent technology. The book reflects significant contributions made by world renowned neurosurgeons Constantinos Hadjipanayis, Walter Stummer, and esteemed contributors on the growing uses of 5-aminolevulinic acid (5-ALA) and other FGS agents.
The European Medicine Agency approved 5-ALA in 2007, heralding the birth of FGS globally. In 2017, the U.S. Food and Drug Administration approved 5-ALA (Gleolan) as an imaging agent to facilitate realtime detection and visualization of malignant tissue during glioma surgery. In the two decades since Dr. Stummer's initial description of 5-ALA FGS in a human patient, major strides have been made in its practical applications, leading to improved resection outcomes. As FGS is increasingly incorporated into neurosurgical practice, it holds promise for future innovations. Generously-illustrated and enhanced with online videos, this textbook is the definitive resource on the subject.
Key Features
- The improved efficacy of 5-ALA for resecting high- and low-grade gliomas, recurrences, meningiomas, brain metastases, spinal cord tumors, pediatric brain tumors, and other adult tumors
- The future of fluorescence, including potentially powerful new fluorophores molecularly targeted specifically to tumors
- The use of the fluorescent agent indocyanine green (ICG) for brain tumors, cerebral aneurysms, AVMs, and cerebral vascularization
- Special topics such as fluorescein, illuminating tumor paint, confocal